Skip to main content
. 2008 Jan 23;2008(1):CD005171. doi: 10.1002/14651858.CD005171.pub2
Methods Randomised controlled trial
Participants Bipolar disorder and schizoaffective disorder
Interventions 4 on oxcarbazepine, 6 on lithium
Outcomes Relapse of disorder
Notes 36 month study . Text documented 15 patients being initally randomised. Rest of five patients not accounted for. All patients on oxcarbazepine dropped out, however no mention of handling of drop outs in final analysis. No subgroup analysis possible as patients having schizoaffective disorder not delineated. All patients discontinued therapy before two years itself, reason for discontinuation for individual patients not described.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? High risk C ‐ Inadequate